CSI Market
Sign In | Register

Qsam Biosciences Inc (APGR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access APGR Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Qsam Biosciences Inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Operating Activities
Income-4.39
Depreciation & amortization0.00
Amortization of Other Assets0.04
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation1.25
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Amortization Of Stock Option Grants And Restricted Stock Unit Grants-
Amortization Of Prepaid Expenses Via Common Stock-
Change In Fair Value Of Convertible Bridge Notes-
Increase In Contract Liabilities Related Parties-
Interest Expense Related Party-
Increase Decrease In Contract With Customer Liability And License Deposits-
Increase Decrease In Accrued Payroll And Related Expenses-
Stockbased Compensation To Employees And Directors-
Stockbased Compensation And Stock Option Modification-
Loss On Conversion Of Bridge Notes And Accrued Interest-
Loss On Conversion Of Debentures And Notes Payable With Unrelated Parties-
Gain On Forgiveness Or Assumption Of Notes Payable And Accrued Expenses-
Inducement Expense0.40
Gain On Forgiveness Of Paycheck Protection Program-
Income taxes0.00
Gain (Loss) on Sale of Equity Investments0.00
Increase (Decrease) in Employee Related Liabilities0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.14
Increase (Decrease) in Interest Payable, Net0.01
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.07
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-2.85
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.01
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Sale Of Comm Stock Rights Offering Net Of Direct Offering Costs-
Proceeds From Paycheck Protection Program-
Proceeds From Convertible Notes Payable-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.01
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-2.85
Total Cash Flow1.16
4 historic quarters locked

Sign in to unlock the full Qsam Biosciences Inc cash flow history.

Sign In Create Free Account

About Qsam Biosciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: March 20, 2024
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-24-010683

Figures are derived from filed reports and may be restated. Historical data is subject to revision.